Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort

ConditionPost-Acute COVID-19 Syndrome

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorHospices Civils de Lyon

About this trial

The study aims to identify clinical profiles of long-COVID patients and correlate them with immunological and molecular data in order to identify prognostic biomarkers and potential therapeutic targets.

Eligibility criteria

Qualifiers

Documented SARS-CoV-2 infection

Persistent or complex post-COVID symptoms lasting more than 4 weeks or more than 3 months

Patient referred to the EPSILON pathway or to the post-COVID rehabilitation unit

Age ≥ 18 years

Disqualifiers

Refusal to participate or to share data

Uncontrolled comorbidities

Pregnant or breastfeeding women

Persons under legal protection or deprived of liberty

Trial design

Treatments tested in this trial

Blood sample collection

Treatment groups

150 Participants

are divided into 1 treatment group

Sponsors and collaborators

Hospices Civils de Lyon

Lead sponsor

Source ClinicalTrials.gov